Next-generation stool DNA test accurately detects colorectal cancer and large adenomas.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Gastroenterology

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/j.gastro.2011.10.031PMID 22062357PMCID PMC4017869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantification of methylated markers with a multiplex methylation-specific technology.

  2012cited by this paper
• Protection From Colorectal Cancer After Colonoscopy

  2011cited by this paper
• Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy.

  2011cited by this paper
• A shift from distal to proximal neoplasia in the colon: a decade of polyps and CRC in Italy

  2010cited by this paper
• Molecular detection of colorectal neoplasia.

  2010cited by this paper
• 743 Noninvasive Detection of Serrated Colorectal Polyps by Stool Assay of Methylated Vimentin and Mutant BRAF Genes

  2010cited by this paper
• Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study.

  2010cited by this paper
• Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

  2010cited by this paper
• NATURAL HISTORY OF SMALL COLORECTAL PROTUBERANT ADENOMAS

  2010cited by this paper
• Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions

  2010cited by this paper
• Approach to the Patient with Occult Gastrointestinal Bleeding

  2009cited by this paper
• Serrated polyps and colorectal cancer: new pathway to malignancy.

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.

  2009cited by this paper
• Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.

  2009cited by this paper
• Next-generation stool DNA testing: expanding the scope.

  2009cited by this paper
• Association of Colonoscopy and Death From Colorectal Cancer

  2009cited by this paper
• International Trends in Colorectal Cancer Incidence Rates

  2009cited by this paper
• Stool Methylation-Specific Polymerase Chain Reaction Assay for the Detection of Colorectal Neoplasia in Korean Patients

  2009cited by this paper
• T2034 Stool DNA and Occult Blood for Detection of Colorectal Cancer: Complementary Markers

  2009cited by this paper
• T2037 Quantitative Stool DNA Testing for Detection of Both Colorectal Cancer and Advanced Adenoma

  2009cited by this paper
• Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients.

  2008cited by this paper
• Principles of Clinical Gastroenterology

  2008cited by this paper
• T1102 Detection of Colorectal Neoplasia By Stool DNA Testing: High Discrimination with Multi-Marker Quantitation

  2008cited by this paper
• Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay

  2008cited by this paper
• Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia

  2008cited by this paper
• Hypermethylation of SFRP2 as a Potential Marker for Stool-Based Detection of Colorectal Cancer and Precancerous Lesions

  2007cited by this paper
• The natural history of colorectal polyps and masses: rediscovered truths from the barium enema era.

  2007cited by this paper
• Improved fecal DNA test for colorectal cancer screening.

  2007cited by this paper
• A Sensitive Method to Quantify Human Long DNA in Stool: Relevance to Colorectal Cancer Screening

  2006cited by this paper
• Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test

  2006cited by this paper
• DNA Stabilization Is Critical for Maximizing Performance of Fecal DNA-Based Colorectal Cancer Tests

  2005cited by this paper
• Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study.

  2005cited by this paper
• Detection and quantification of mutations in the plasma of patients with colorectal tumors.

  2005cited by this paper
• A Comparison of the Immunochemical Fecal Occult Blood Test and Total Colonoscopy in the Asymptomatic Population

  2005cited by this paper
• A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.

  2005cited by this paper
• National Polyp Study data: Evidence for regression of adenomas

  2004cited by this paper
• Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.

  2004cited by this paper
• Continued Rightward Shift of Colorectal Cancer

  2002cited by this paper
• Detection of occult upper gastrointestinal tract bleeding: performance differences in fecal occult blood tests.

  2002cited by this paper
• DNA methylation in cancer: too much, but also too little

  2002cited by this paper
• Combining Several Screening Tests: Optimality of the Risk Score

  2002cited by this paper
• Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.

  2000cited by this paper
• A note on a concordance correlation coefficient to evaluate reproducibility

  1997cited by this paper
• The pathologic measurement of polyp size is preferable to the endoscopic estimate.

  1997cited by this paper
• Detection of rRNA from four respiratory pathogens using an automated Q beta replicase assay.

  1996cited by this paper
• Growth of colorectal polyps: recovery and evaluation of unresected polyps of less than 10 mm, 1 year after detection.

  1994cited by this paper
• Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.

  1993cited by this paper
• Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.

  1992cited by this paper
• A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.

  1992cited by this paper
• A concordance correlation coefficient to evaluate reproducibility.

  1989cited by this paper
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper
• Natural history of untreated colonic polyps.

  1987cited by this paper
• Fecal blood levels in health and disease. A study using HemoQuant.

  1985cited by this paper
• HemoQuant, a new quantitative assay for fecal hemoglobin. Comparison with Hemoccult.

  1984cited by this paper
• The evolution of cancer of the colon and rectum

  1975cited by this paper
• THE RATES AND PATTERNS OF GROWTH OF 375 TUMORS OF THE LARGE INTESTINE AND RECTUM OBSERVED SERIALLY BY DOUBLE CONTRAST ENEMA STUDY (MALMOE TECHNIQUE).

  1963cited by this paper
• GROWTH RATE AND MALIGNANT POTENTIAL OF COLONIC POLYPS: EARLY RESULTS.

  1963cited by this paper
• GROWTH RATE AND MALIGNANT POTENTIAL OF COLONIC POLYPS: EARLY RESULTS.

  1963cited by this paper

• Ultrasensitive and label-free detection of piR-54265 biomarker by solution-gated graphene transistors with poly-adenine DNA assembled probe for accurate diagnosis of colorectal cancer

  2026cites this paper
• Non-invasive colorectal cancer screening methods: focusing on diagnostic genetic and epigenetic markers

  2025cites this paper
• Colorectal cancer worldwide: epidemiological trends, economic burden, and the promise of AI-driven solutions

  2025cites this paper
• Methylation of SEPT9 and LINC00473 Genes in Circulating Cell-Free DNA as a Potential Biomarker for the Early Detection of Colorectal Polyps

  2025cites this paper
• Application of the Colorectal Cancer (CRC) Screening Guiding Principles for Non-invasive Testing to Multi-target Stool DNA: A Case Study

  2025cites this paper
• Beyond colonoscopy, faecal DNA mutation screening provides a potential and viable path to early colorectal cancer detection

  2025cites this paper
• Real-world analysis of community colorectal neoplasia screening based on stool DNA methylation detection

  2025cites this paper
• Significance of Fusobacterium nucleatum Combined with SFRP2 and SDC2 Gene Methylation Detection in Early Screening of Colorectal Cancer

  2025cites this paper
• Effectiveness of single-target fecal DNA methylation test in regional mass screening for colorectal cancer and precancerous lesions in China

  2025cites this paper
• Evaluation of NEUROG1 methylation status in stool specimens in the advanced adenomas and colorectal cancer

  2025cites this paper
• Multi-STEM MePCR: a bisulfite-free, multiplex, highly sensitive and highly specific assay to measure DNA methylation

  2025cites this paper
• Optical diagnostics of liver tumors using an autofluorescence lifetime probe

  2025cites this paper
• Diagnostic value of genetic and epigenetic biomarker panels for colorectal cancer detection: a systematic review

  2025influential citation
• DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicine

  2024cites this paper
• Developing a Nomogram for Predicting Colorectal Cancer and Its Precancerous Lesions Based on Data from Three Non-Invasive Screening Tools, APCS, FIT, and sDNA

  2024cites this paper
• Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis

  2024cites this paper
• Dépistage du cancer colorectal

  2024cites this paper
• Dual Role of Tissue Factor Pathway Inhibitor 2—A Novel Serodiagnostic Marker for Ovarian Cancer—In Human Cancers

  2024cites this paper
• Research progress and applications of epigenetic biomarkers in cancer

  2024cites this paper
• Frameshift mutations in peripheral blood as a biomarker for surveillance of lynch syndrome.

  2024cites this paper
• Deciphering Cancer's Code: A Review on Advanced Machine Learning Approaches in DNA-Based Cancer Detection

  2024cites this paper
• Evaluating the clinical performance of SDC2/NDRG4 methylation for colorectal cancer detection.

  2024cites this paper
• Discovery and validation of colorectal cancer tissue-specific methylation markers: a dual-center retrospective cohort study

  2024cites this paper
• DNA Methylation Biomarkers in Stool Samples: Enhancing Colorectal Cancer Screening Strategies

  2024cites this paper
• Utility of methylated DNA markers for the diagnosis of malignant biliary strictures.

  2024cites this paper
• Noninvasive colorectal cancer screening techniques: literature review

  2023cites this paper
• Taxonomic and functional profiling of fecal metagenomes for the early detection of colorectal cancer

  2023cites this paper
• Potential prognostic and predictive value of UBE2N, IMPDH1, DYNC1LI1 and HRASLS2 in colorectal cancer stool specimens

  2023cites this paper
• Detection of endometrial cancer using tampon-based collection and methylated DNA markers.

  2023cites this paper
• Methods and biomarkers for early detection, prediction, and diagnosis of colorectal cancer.

  2023cites this paper
• Multitarget Stool DNA Testing Has High Positive Predictive Value for Colorectal Neoplasia on the Second Round of Testing.

  2023cites this paper
• A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma

  2023cites this paper
• Comprehensive Cost Implications of Commercially Available Noninvasive Colorectal Cancer Screening Modalities.

  2023cites this paper
• Cross-sectional risk models using quantitative fecal hemoglobin in colorectal cancer screening: a systematic review

  2023cites this paper
• DNA Methylation-Based Testing in Peripheral Blood Mononuclear Cells Enables Accurate and Early Detection of Colorectal Cancer

  2023cites this paper
• Diagnostic Accuracy of Multitarget Stool DNA Testing for Colorectal Cancer Screening: A Systematic Review and Meta-analysis.

  2022cites this paper
• DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.

  2022cites this paper
• A Novel Stool Methylation Test for the Non-Invasive Screening of Gastric and Colorectal Cancer

  2022cites this paper
• Early detection and prognosis prediction for colorectal cancer by circulating tumour DNA methylation haplotypes: A multicentre cohort study

  2022cites this paper
• Discovery and validation of tissue-specific DNA methylation as noninvasive diagnostic markers for colorectal cancer

  2022cites this paper
• Detection of Fusobacterium nucleatum DNA in primary care patient stool samples does not predict progression of colorectal neoplasia

  2022cites this paper
• Epigenetic insights in the diagnosis, prognosis, and treatment selection in CRC, an updated review

  2022cites this paper
• DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine

  2022cites this paper
• A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA

  2022cites this paper
• Relation between expression of hMLH1 and p53 mRNA genes, in the feces of patients with colorectal carcinoma. Cross-sectional study

  2022cites this paper
• Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria Analysis

  2021cites this paper
• The impact of DNA testing on management of patients with colorectal cancer

  2021cites this paper
• Combined detection of stool-based methylation indicators for early screening of colorectal neoplasm

  2021cites this paper
• DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma

  2021cites this paper
• Fecal neopterin level determination: can be a useful screening test for colorectal polyps?

  2021cites this paper
• Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC

  2021cites this paper
• The stool syndecan2 methylation test is more robust than blood tests for methylated septin9, CEA, CA19-9 and CA724: a diagnostic test for the early detection of colorectal neoplasms

  2021cites this paper
• Performance evaluation of stool DNA methylation tests in colorectal cancer screening: a systematic review and meta‐analysis

  2021cites this paper
• Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers: A Systematic Review and Meta-Analysis

  2021cites this paper
• Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer

  2021cites this paper
• A New Method for the Detection of Colorectal Cancer and the Precancerous Lesions: Occult Blood Testing Combination with Promoter Methylation in the Fecal Sample

  2021cites this paper
• Quantifying procedural pain associated with office gynecologic tract sampling methods.

  2021cites this paper
• Detection of SHOX2 DNA methylation by methylation-specific PCR in non-small cell lung cancer

  2020cites this paper
• Faecal DNA Testing for Detection of Colorectal Carcinoma: A Prospective Case Control Study

  2020influential citation
• Early Detection and Recurrence of Colorectal Adenomas by Combination of Eight Cancer-Associated Biomarkers in Plasma

  2020cites this paper
• DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples

  2020cites this paper
• Multitarget stool DNA test compared with fecal occult blood test for colorectal cancer screening

  2020cites this paper
• Non-Invasive Colorectal Cancer Screening: An Overview

  2020cites this paper
• A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screening

  2020cites this paper
• Biomarker measurement in non-invasively sampled colorectal mucus as a novel approach to colorectal cancer detection: screening and triage implications

  2020cites this paper
• Multitarget Stool DNA for Average Risk Colorectal Cancer Screening: Major Achievements and Future Directions.

  2020cites this paper
• A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers

  2020cites this paper
• Colorectal Cancer Screening With the Multitarget Stool DNA Test

  2020cites this paper
• A mountable toilet system for personalized health monitoring via the analysis of excreta

  2020cites this paper
• Multi-Target Stool DNA Testing for Colorectal Cancer Screening: Emerging Learning on Real-world Performance

  2020cites this paper
• Emerging Designs of Electronic Devices in Biomedicine

  2020cites this paper
• Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy

  2020cites this paper
• Trends, Risk Factors, and Preventions in Colorectal Cancer

  2020cites this paper
• Tiny but mighty: use of next generation sequencing on discarded cytocentrifuged bile duct brushing specimens to increase sensitivity of cytological diagnosis

  2020cites this paper
• Fecal DNA Testing for Colorectal Cancer Screening.

  2020cites this paper
• Biomarkers for detecting colorectal cancer non-invasively: DNA, RNA or proteins?

  2020cites this paper
• Urinary 1H-NMR Metabolic Signature in Subjects Undergoing Colonoscopy for Colon Cancer Diagnosis

  2020cites this paper
• Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study

  2020cites this paper
• Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.

  2020cites this paper
• Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA.

  2020cites this paper
• Pathology, Biomarkers, and Molecular Diagnostics

  2020cites this paper
• CEG_A_251633 273..284

  2020cites this paper
• Multitarget Stool DNA Test Versus Fecal Occult Blood Test for Colorectal Cancer Screening

  2020cites this paper
• Uncovering epigenetic landscape: a new path for biomarkers identification and drug development

  2020cites this paper
• Hypermethylation-mediated silencing of NDRG4 promotes pancreatic ductal adenocarcinoma by regulating mitochondrial function

  2020cites this paper
• Colorectal carcinoma screening: Established methods and emerging technology

  2020cites this paper
• A Simple and Highly Specific MassARRAY-Based Stool DNA Assay to Prioritize Follow-up Decisions in Fecal Immunochemical Test-Positive Individuals

  2019cites this paper
• Colorectal cancer screening: a minireview

  2019cites this paper
• A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.

  2019cites this paper
• High-Yield Methylation Markers for Stool-Based Detection of Colorectal Cancer

  2019cites this paper
• Response to GASTRO-D-19-02091.

  2019cites this paper
• Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population

  2019cites this paper
• Fecal occult blood test in colorectal cancer screening

  2019cites this paper
• 1H NMR‐based metabolomics reveal overlapping discriminatory metabolites and metabolic pathway disturbances between colorectal tumor tissues and fecal samples

  2019cites this paper
• DNA methylation detection methods used in colorectal cancer

  2019cites this paper
• Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA

  2019cites this paper
• Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma

  2019cites this paper
• Colorectal Cancer Screening and Surveillance

  2019cites this paper
• Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High‐Grade Dysplasia in Patients With Inflammatory Bowel Disease

  2019cites this paper
• The New Bench for the Academic Surgeon: Precision Medicine

  2019cites this paper